Buradasınız

Anasayfa » Content

LOKOPLAKI KÖKENLİ EPIDERMOID KARSİNOM (2 VAK A NEDENİYLE)

EPIDERMOID CARCINOMA OF LEUKOP LASTIC ORIGIN (REPORT OF TWO CASES)

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 1998

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Leukoplakia is defined, by WHO (World Health Organization) as a keratotic white plaque that is unscrapable and cannot be diagnosed specifically as any other lesion. Leukoplakia is seen mostfrequently in men older than 40 in any site of die mouth. Histologic changes range from hyperkeratosis, acanthosis, dysplasia and carcinoma in situ. The cases presented are diagnosed as epidermoid carcinoma of le-ukoplastic origin. The aim of this article is to shed light on the diagnosis and treatment of leukoplakia.
Bookmark/Search this post with
Abstract (Original Language): 
Lökoplaki WHO (Dünya Sağlık Örgütü) tarafından, kazınamayan ve başka bir spesifik diagnostik isim verilemeyen keratotik, beyaz plak olarak tanımlanmıştır. Lökoplaki genellikle 40 yaşın üzerinde, erkeklerde ve ağızın her bölümünde görülebilir. Histopatolojİk görüntü hiperkeratoz, akantoz, displazi ve in situ karshıo-maya kadar değişebilir. Olgularımız lökoplaki kökenli epidermoid karsinom tanısı konulan iki hastadır. Bu yazının amacı prekanserÖz bir lezyon olan lökoplaki-nin teşhis ve tedavisine ışık tutmaktır.
FULL TEXT (PDF): 
PDF icon arastirmax-lokoplaki-kokenli-epidermoid-karsinom-2-vak-nedeniyle.pdf
  • 1
34
38
  • Turkish

REFERENCES

References: 

1. BanoczyJ, Csiba A. Occurrence of epithelial dysplasia in oral leukoplakia. Oral Med Oral Pathol 1976; 42:766.
2. Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK Regression of oral leukoplakia with a-tocopherol: A community Clinical Oncology Program Chemoprevention Study. Journal of the National Cancer Institute 1993; 85:44-7.
3. Bertram JS, Kolonel LN, Meykens FL. Rationale and strategies for chemoprevention of cancer in humans. Cancer Jfcsl987: 47:3012-31.
4. Bouqout JE, Weiland LH, Kurland LT. Leukoplakia and carcinoma in situ synhronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Mİn, 1935¬1984. Oral Surg Oral Med Oral Pathol 1988; 65: 199-207.
5. BouquotJE. Reviewing oral leukoplakia-Clinical concepts for the 1990s. J Am Dent Assoc 1991:122:80-32.
6. Bouqout JE, Whitaker JB. Oral leukoplakia-Rationale for diagnosis and prognosis of its clinical subtypes or "phases". Quintessence Intl994: 25:133-40.
7. Chu FWK, Silvarman S, Dedo HH. C02 Laser treatment of oral leukoplakia. Laryngocsope 1988: 98:125-30.
8. Daftary DK, Mehta FS, Gupta PC; Pindborg JJ. The presence of Candida in 723 oral leukoplakia among Indian villagers. ScandJDentRes 1972: 8:75.
9. Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa Cancer 1967: 20:2189.
10. Fleiner B, Lüttges J, Haffmeister B. Histologische beurteilbarkeit von mundschleimhautverânderungen nach C02-Laserresektion. Dtsch Zahnarztl Z, 1993: 48-53-5.
11. Gerlach KL, RoodenburgJLN, Herzog M, Horch H, Panders AK, Pape HD, Fe'aux de Le Croix W, Vermey A. Die
Therapİe
orale
r leukoplakien mit dem C02 laser. Dtsch ZahnarztlZ 1993: 48:48-50.
12. Girod SC, Fischer U, Knüfermann R, Kramer Ch, Krüger GRF, p53-Mutationen bei leukoplakien, lichen planus und karzinomen der Mundschleimhaut. Dtsch ZMund Kiefer Gesichts Chir 1994: 18:250-3.
13. Jones JH, Mason DK. Oral Manifestations of Systemic Disease. Second Ed. London: Bailliere Tindall: 1990; 561-6.
14. Kaugars GE, Brandt RB, Carcaise-Edinboro P, Strauss R. Beta-carotene supplementation in the treatment of oral lesions [Abstract]. Oral Surg Oral Med Oral Pathol 1990; 70:607-8.
15. Kaugars GE, Silverman S, Lovas JGL, Thompson JS, Brandt RB, Singh VN, Use of antioxidant supplements in the treatment of human oral leukoplakia, Oral Surg Oral Med Oral Pathol 1996: 81:5-14.
16. Krutchkoff DJ. Differential Diagnosis of white lesions of oral mucosa. BuÜ ofKanagawa Dent Col 1988:16:5-10.
17. Mocan A. Ağız mukozasının prekanserÖz lezyonlan. AÖDiş Hek Fak Derg 1979: 6:83-104.
18. RegeziJA, SciubbaJ. Oral Pathology. Second Ed. Philadelphia: WB Saunders Company 1993: 114-20.
19. Renstrup G. Occurrence of Candida in oral leukoplakias. Acta Pathol. Microbiol Scand 1970: 78:42.
20. Roed-Petersen B; Renstrup G, Pindborg JJ. Candida in oral leukoplakia. Scand J Dent Res 1970; 78: 323-8.
21. Scully C. Clinical Dentistry in Health and Disease, The Mouth and perioral tissues. Oxford: Heineman Medical Books, 1989.
22. Seifert G, Bukhardt A. Neuere morphologische Ge-sichtspunkte bei malignen Tumoren der Mundschleimhaut.Dtsch Med Wschr 1977: 102:1596.
23. Silverman S, Gorsky M, Lozada F, Leukoplakia and Malignant Transformation, A Follow-up study of 257 Patients. Cancer 1984; 53:563-8.
24. Sonis S, Fazio R, Fang L. Principles and practice of Oral Medicine 2nd ed. WB Saunders Com. Philadelphia 1995.
25. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 1975: 36:1386-92.
26. WHO. Definition of leukoplakia and related lesions; an aid studies on oral precancer. Oral Surg 1978: 46:518-39.
27. Wilsch L, Hornstein OP, Brüning H; Schwigger V et al. Orale leukoplakien II. Ergebnisse einer 1 jahrigen polikli-nischen Pilotstudie. Dtsch ZahnarzÜ Z 1978:33:132-42.
28. Wood NK, Goaz PW. Differential Diagnosis of oral lesions. Fourth ed. St Louis, Mosby Year Book. 1991.
29. ZakrzewskaJM, Lopes V, Speight P, Hopper C. Proliferative verrucous leukoplakia, A report of ten cases Oral Surg Oral Med OmlPathol 1996: 82:396-401.

Thank you for copying data from http://www.arastirmax.com